Barclays Forecasts Strong Price Appreciation for Tandem Diabetes Care (NASDAQ:TNDM) Stock
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective boosted by equities researchers at Barclays from $58.00 to $60.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical device company’s stock. Barclays‘s target price would suggest a potential upside of 92.86% […]
More Stories
Portugal’s Cristiano Ronaldo Announces International Retirement
By The Associated Press Cristiano Ronaldo won’t play for Portugal anymore, ending on Thursday a career that spanned six World...
IRS Unveils 2027 Federal Income Tax Brackets
By Naveen Athrappully Federal tax authorities announced higher income tax brackets and other annual inflation adjustments for tax year 2027....
US Economy Adds 165,000 New Jobs in October, Unemployment Rate Dips to 4.1 Percent
By Andrew Moran Employment conditions strengthened in October as job growth blew past economists’ forecasts and the unemployment rate unexpectedly...
Trump Blames Democrats’ Midterm Victory for Stock Market Losses
By Jack Phillips President Donald Trump on Thursday said a stock market drop that day was due to Democrats winning...
Victor Davis Hanson Discusses What’s Next for GOP, Possible 2028 Contenders
By Timothy Frudd and Jan Jekielek President Donald Trump can still wield considerable political power over the next two years...
US Imposes Sanctions Targeting Iran’s Efforts to Obtain Air Defense Systems
By Timothy Frudd The Trump administration announced new sanctions on Wednesday targeting two individuals and one entity linked to Iran’s...